AKAlla S. Kalugina

Alla S. Kalugina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alla S. Kalugina has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ability of using granulocyte colony-stimulating factor in reproductive medicine

    by I.A. Babenchuk, K.S. Tatishcheva, D.A. Lobzeva, D.A. Gerkulov, A.S. Kalugina

    Assuming the increasing infertility frequency in many developed countries, connected both to a growing anthropogenic factor influence and sustained tendency of reproductive plans realization’s postponement for advanced years, this review is dedicated to the pressing problem in modern medicine: increasing the ART program’s efficacy in patients with the recurrent implantation failures. In this regard, the role of G-KSF in a regulation of ovarian functioning, folliculogenesis, ovulation, oocyte competence’s formation has been covered in detail. There is a distinct part in the article devoted to a role of G-KSF in a process of embryo implantation within the natural pregnancy and ART programs. According to the numerous scientific data related to G-KSF, it has a direct regulatory effect on the main processes associated with the reproductive function’s implementation such as oocyte maturation, process of ovulation, fertilization and embryo development, trophoblast invasion as well as the placentation support. The potential of a clinical use of G-KSF medication in different groups of patients with infertility is considered. There’re results of randomized and cohort studies aimed at efficacy and safety of use presented. It seems highly promising the realization of such medications in order to increase ART efficacy, especially in cases with the repeated implantation failures and advanced reproductive aged groups.

  • Open Access

    The effect of spermatogenesis stimulation on embryological outcomes in assisted reproductive technology programs for patients with pathospermia: a prospective cohort study

    by Jekaterina Prikulis, Прикулис Екатерина, Alla S. Kalugina, Калугина Алла Станиславовна, Yulia A. Tatishcheva, Татищева Юлия Александровна, Sergei Yu. Frolov, Фролов Сергей Юрьевич, Tatyana V. Ronis, Ронис Татьяна Вячеславовна, et al.

    BACKGROUND: Despite the widespread use of assisted reproductive technology (ART) treatments, the impact of the male factor on embryo quality remains insufficiently understood. Data regarding the effect of preconception stimulation of spermatogenesis on embryological outcomes in patients with pathospermia are limited and contradictory, which underscores the relevance of the present study. AIM: The aim of this study was to evaluate the effect of preconception care in men with pathospermia on spermatogenesis parameters and embryological outcomes in ART programs. METHODS: This prospective comparative study included 92 men with pathospermia undergoing ART treatment. The intervention group (n = 44) received a course of spermatogenesis stimulation therapy, whereas the control group (n = 48) underwent ART without prior preparation. The study groups were comparable in terms of male and female age, number of mature oocytes, and baseline semen characteristics. We assessed changes in spermatogenesis parameters and embryological outcomes, including the normal fertilization rate, number of day-5 embryos, total number of embryos obtained, and number of high-quality embryos. RESULTS: In the intervention group, sperm concentration, progressive motility, and normal morphology improved significantly following the stimulation therapy. However, we observed no effect of spermatogenesis stimulation on the fertilization rate (odds ratio 1.197; 95% confidence interval 0.860–1.665). In addition, the intervention group demonstrated higher numbers of day-5 embryos (p = 0.031), total embryos obtained (p = 0.041), and high-quality embryos (p = 0.045). The odds of obtaining a high-quality embryo were nearly twofold higher in patients who underwent spermatogenesis stimulation (odds ratio 1.88; 95% confidence interval 1.053–3.357). CONCLUSION: Male preconception care improves semen parameters and enhances embryo quality but does not affect fertilization rates in ART cycles. The observed effect is likely associated with improved sperm DNA integrity, which is not reflected by conventional semen analysis parameters. These findings support the use of spermatogenesis stimulation to optimize embryological outcomes and improve ART effectiveness. Further research is required to evaluate the impact of this approach on clinical ART outcomes, including pregnancy and live birth rates.

  • Embryo Ploidy in Women of Different Age Groups Depending on the Comprehensive Assessment of Morphokinetic Parameters KIDScoreD5 v3.2.

    by N. A. Slominskaya, Y. A. Tatishcheva, N. A. Kuzminih, O. S. Pryadkina, A. S. Kalugina, D. A. Gerkulov, I. A. Babenchuk

    Background: The identification of non-invasive markers for selecting the most promising embryo is extremely important today. Morphological assessment is the basic criterion for embryo evaluation in in vitro fertilization (IVF) cycles. However, data on the correlation between embryo morphology, euploidy, and implantation potential are conflicting. With the advent of time-lapse incubators, it has become possible to assess morphokinetic parameters of embryo development and to use them for predicting both ploidy and implantation potential. Based on the morphokinetics of day 5–6 embryos, the computer software of time-lapse incubators provides an automated assessment of embryo implantation potential (KIDScoreD5). This algorithm was developed taking into account the currently known morphokinetic parameters most significant for embryo implantation: cleavage uniformity, blastocyst formation time, and the quality of the inner cell mass and trophectoderm. KIDScoreD5 allows ranking of embryos, which is particularly relevant when several embryos with similar morphology are available. Objective: To evaluate the relationship between KIDScoreD5 and embryo ploidy, and to assess the effectiveness of KIDScoreD5 in predicting embryo ploidy in patients of different age groups. Materials and methods: A retrospective analysis was performed on 1124 embryos with known ploidy obtained from 418 patients undergoing infertility treatment at the Skyfert Clinic in St. Petersburg from January 1, 2021, to March 31, 2025. The mean KIDScoreD5 score of day 5 and day 6 embryos that underwent PGT-A was assessed in two age groups: under 37 years and 37 years and older. The Mann-Whitney test was used for group comparisons. Spearman’s rank correlation coefficient was calculated to assess the relationship between quantitative variables. ROC analysis was used to evaluate the predictive quality of individual parameters and of our developed model for calculating the probability of embryo euploidy. Binary logistic regression was used to assess the relationship between maternal age, KIDScoreD5 score, embryo developmental day, and embryo ploidy. Results: The frequency of euploid embryos decreased significantly with increasing maternal age starting from 37 years (p < 0.0001), based on which patients were divided into two age groups: under 37 years and 37 years and older. The frequency of euploid embryos differed significantly between the two age groups (60.1 and 30.4%, respectively, p < 0.0001) and was also significantly lower in day 6 embryos compared with day 5 embryos (32.3 and 46.8%, respectively, p < 0.0001). KIDScoreD5 scores were significantly higher in euploid embryos, regardless of maternal age and embryo developmental day (p < 0.0001). The correlation between KIDScoreD5 of euploid embryos and maternal age was not significant (p > 0.05). ROC analysis showed that KIDScoreD5 is a significant predictor of ploidy of satisfactory quality, regardless of maternal age and embryo developmental day. Binary logistic regression showed that maternal age and KIDScoreD5 score are independently associated with embryo euploidy (p < 0.0001). Specifically, with each one-year increase in age, the probability of euploidy decreases by 16.6%, while with each one-point increase in KIDScoreD5 score, the probability increases by 33%. Based on these data, a formula was derived for calculating the probability of embryo euploidy considering maternal age and KIDScoreD5 score. ROC analysis showed good predictive quality of the obtained model: AUC 0.732 (0.703:0.761). Conclusions: KIDScoreD5 can serve as an additional tool for embryologists in selecting embryos for PGT-A, helping to reduce the financial burden on patients and the time to embryo transfer after PGT-A. A prospective study is needed to validate our model for predicting embryo euploidy based on KIDScoreD5 and maternal age.

  • Evaluation of the effect of the combined antioxidant preparation Megaspermin Maca on spermatogenesis parameters and DNA fragmentation levels in men with idiopathic pathospermia

    by J. Prikulis, O.B. Zhukov, V.V. Kotov, S.V. Bogolyubov, D.A. Niauri, A.S. Kalugina, A.M. Gzgzyan

    Male factor infertility remains one of the leading causes of reduced reproductive potential in couples, accounting for up to 50% of infertility cases. Traditional semen analysis parameters do not always reflect the true fertility status, as a significant proportion of men with normal ejaculate parameters are diagnosed with impaired sperm genetic integrity. One of the key mechanisms of sperm damage is oxidative stress. Consequently, pathogenetically substantiated complex antioxidant and metabolic support for spermatogenesis is of particular interest. Objective. To evaluate changes in spermatogenesis parameters and sperm DNA fragmentation levels in men with idiopathic pathospermia following administration of a combined antioxidant complex. Material and methods. A multicenter observational study included 118 men aged 25—55 years with idiopathic pathospermia. Participants received a combined antioxidant complex for 90 days. The following parameters were assessed: ejaculate volume, sperm concentration, progressive motility, sperm morphology and the level of DNA fragmentation measured by the TUNEL assay. Semen analysis was performed before the initiation of therapy and after three months of therapy. Results. Administration of the studied complex was associated with statistically significant improvement in the main parameters (volume, concentration, progressive motility and sperm morphology) and a reduction in DNA fragmentation levels (p<0.001). Positive dynamics of the corresponding parameters were noted in subgroups of patients with baseline oligozoospermia, asthenozoospermia and teratozoospermia (p<0.05). Conclusions. The use of combined antioxidant complex was associated with a statistically significant improvement in spermatogenesis parameters and a decrease in sperm DNA fragmentation levels in men with idiopathic pathospermia. The obtained findings suggest that pathogenetically oriented nutritional antioxidant support may represent a potentially promising approach for the management of spermatogenesis disorders. However, the observational design of the study and the absence of a control group limit the possibility of causal interpretation of the observed changes. Further randomized controlled studies are required to further evaluate these findings and their potential clinical significance.

  • Open Access

    Successful pregnancy after fertility preservation using OTO-IVM method in ovarian cancer

    by O. E. Lavrinovich, Yu. A. Tatischeva, D. A. Gerkulov, N. A. Slominskaya, I. V. Berlev, M. G. Yakovleva, A. P. Karitski, A. S. Kalugina

    Fertility preservation in women of reproductive age with ovarian cancer is still challenging. The ovarian-sparing surgery may increase the risk of recurrence. The direct involvement of the ovary in the tumor process significantly limits the ability to implement the most effective fertility preservation methods. For example, ovarian stimulation and ovarian cortex cryopreservation are absolutely contraindicated due to the risk of tumor cell contamination. In such cases, the only feasible fertility preservation method may be OTO-IVM (Ovarian Tissue Oocyte In Vitro Maturation), which involves retrieving immature oocytes from ovarian tissue removed during surgery and subsequent in vitro maturation.Clinical Case Description. We present a case of successful pregnancy achieved through comprehensive, multidisciplinary fertility preservation. A 30-year-old patient with a recurrent borderline ovarian tumor in her only remaining ovary underwent surgery with uterine preservation and removal of the affected ovary. From the tumor-involved ovary, 22 cumulus-oocyte complexes were obtained. Following OTO-IVM, 12 metaphase II oocytes were obtained and fertilized via intracytoplasmic sperm injection (ICSI) that resulted in 3 blastocyst-stage embryos, which were cryopreserved. Cyclic hormone replacement therapy was administered to the patient. Nine months later, one embryo was thawed and transferred into the uterine cavity. Currently, an ongoing 20-week pregnancy has been confirmed.Conclusion. The OTO-IVM method holds significant value as a fertility preservation technique for patients with ovarian cancer, making childbirth achievable. Further research is needed to refine the method, optimize protocols, and define clear indications and contraindications for its application.

  • Open Access

    OTO-IVM is a method of fertility preservation for patients with ovarian tumors

    by O. E. Lavrinovich, Yu. A. Tatischeva, I. V. Berlev, M. G. Yakovleva, A. P. Karitski, A. S. Kalugina

    Introduction. An increasing number of patients of reproductive age get cancer and are highly interested in preserving fertility. Survival rates for cancer patients are improving. Methods of reproductive technologies are being improved to preserve the ability to bear children. Rehabilitation aimed to ensure a satisfactory quality of life takes on a new meaning, and with the development of new technologies, the level of possible assistance also changes. Today, rehabilitation measures for cancer patients of reproductive age should undoubtedly include all possible ways to preserve and restore fertility. Aim: preservation of fertility in patients with ovarian tumors. Material and Methods. After ovariectomy, the ovaries were transported to the embryology laboratory, where oocyte-cumulus complexes were extracted and subsequently matured using the OTO-IVM (ovarian tissue oocyte in vitro maturation) method. The resulting mature oocytes (Metaphase II) were cryopreserved by vitrification or, if a partner was available, fertilized by ICSI (intracytoplasmic sperm injection), the embryos were cultured to the blastocyst stage and also cryopreserved by vitrification. Cryopreserved oocytes and embryos can be used by patients after cancer treatment in assisted reproductive technology programs. Results. A total of 218 OCCs were recovered, 29.8 % were degraded oocytes (n=65). The proportion of OCC suitable for ripening was 153 (70.2 %). After 36 or 48 hours, 65 oocytes matured in 13 patients, which amounted to 42.5 % of oocytes without signs of degradation. In 11 patients the OCC was removed from the tumor-affected ovary. 149 oocytes were obtained, of which 50 (33.6 %) were oocytes with signs of degradation. The remaining 99 (66.4 %) of OCCs had satisfactory quality; after maturation, the Metaphase II stage reached in 49 (49.5 %) of oocytes. As a result, biological material was cryopreserved in 13 of 15 patients: 5 embryos and 60 oocytes.


  • Open Access

    Management strategies for POSEIDON patients with poor ovarian response to ovarian stimulation: а literature review

    by Yuliya A. Dumanskaya, Alla S. Kalugina

    A poor ovarian response to ovarian stimulation is a factor that significantly reduces the effectiveness of in vitro fertilization programs. Managing these patients remains an unresolved issue in assisted reproductive technology programs. The difficulties are largely determined by the heterogeneity of groups of patients with a poor ovarian response and the need for a personalized approach to ovarian stimulation. This review covers the data from the global literature on the management tactics of patients with a poor ovarian response according to the POSEIDON classification, with the aim of increasing the quantity and quality of retrieved oocytes and clinical pregnancy rates.


  • Adenomyosis and fertility: a modern view of the problem. A literature review

    by Vitaly F. Bezhenar, Viktor A. Linde, Byuzand V. Arakelyan, Alla S. Kalugina, Yuri V. Vasilyev, Darya A. Sobakina, Elmina E. Sadykhova, Viktoria A. Tarasenkova, Аракелян Бюзанд Вазгенович, Васильев Юрий Валерианович

    This literature review is based on resources from the following databases: CyberLeninka, PubMed, MedArt, and the Central Scientific Medical Library (I.M. Sechenov First Moscow State Medical University, Moscow, Russia). Adenomyosis is a common non-infectious uterine pathology associated with the risk of infertility and obstetric problems. The local inflammation that develops in adenomyosis reduces the probability of blastocyst implantation and creates an unfavorable environment for the development of the embryo. Adenomyosis reduces the effectiveness of assisted reproductive technology. During the pregnancy in adenomyosis, the risk of incomplete and prolonged pregnancy increases at almost all stages. Besides, the risk of massive hemorrhage increases during pregnancy, childbirth and the early postpartum period. The presented review helps to assess the pathogenetic mechanisms underlying the negative effect of adenomyosis on womens fertility based on data obtained over the past ten years.


  • Open Access

    Comparative effectiveness of infertility treatment using assisted reproductive technologies in patients with various forms of endometriosis and its combination with polycystic ovary syndrome

    by Alexander A. Makolkin, Alla S. Kalugina

    AIM: The purpose of this study is to investigate the influence of various forms of endometriosis and its combination with PCOS on the outcome of assisted reproductive technology programs (ART) with relation to ovarian stimulation. MATERIALS AND METHODS: During a retrospective examination, we analyzed the results of 241 ART cycles. All patients were divided into three groups: group A: endometriosis (85 ART cycles); group B: combination with PCOS (53 ART cycles), comparison group with tuboperitoneal infertility (103 ART cycles). Group A was subdivided into subgroup A1 with stage I / II endometriosis (50 cases, 58.82%) and subgroup A2 with stage III / IV endometriosis (35 cases, 41.18%). At the first stage of the study, we evaluated the anamnesis and the results of clinical and laboratory tests. During the second stage, we performed laparo- and hysteroscopy surgeries and determined the stage of endometriosis as well as the presence of concomitant pathologies. At the third stage, we performed infertility treatment using ART. RESULTS: The highest FSH dose was employed in group A2 with the ovarian stimulation performed with GnRH-a: 2230.80 614.09 IU. The minimal dose was used for group A1 (stimulation with antGnRH): 1171.43 547.42 IU. The highest pregnancy rate per embryo transfer (PR) was detected in group A1 with the use of GnRH-a (50%,) higher than in the comparison group (42.72%). The minimal PR (14.29%) was found in group A2 (stimulation with antGnRH). Live Birth Rate (LBR) was higher in A1 patients stimulated with GnRH-a (40.48%), while with the use of antGnRH, all pregnancies terminated in both groups A1 and A2. CONCLUSIONS: Our study confirmed that common forms of endometriosis are associated with a decrease in the effectiveness of infertility treatment using ART, but minimal forms of endometriosis do not affect the outcomes of ART cycles. The study revealed a negative impact of an ovarian stimulation protocol with the use of antGnRH on IVF outcomes including patients with the combination of endometriosis and PCOS. However, the small number of cases studied dictates further research to be conducted in this field.